⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4944210 | 0.67 | — | — | |
| SCHEMBL4944214 | 0.67 | — | — | |
| SCHEMBL2142076 | 0.67 | — | — | |
| SCHEMBL11247855 | 0.67 | — | — | |
| SCHEMBL33343 | 0.64 | — | — | |
| SCHEMBL1020321 | 0.62 | — | — | |
| SCHEMBL5518857 | 0.61 | — | — | |
| SCHEMBL3061345 | 0.61 | — | — | |
| SCHEMBL208335 | 0.61 | — | — | |
| SCHEMBL3061340 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1309589-A2 | UREA COMPOUNDS AND METHODS OF USES | Amgen Inc. (US) | 2003-05-14 | — | — | EP | claimed |
| WO-2002014311-A2 | UREA COMPOUNDS AND METHODS OF USES | AMGEN INC. (US) | 2002-02-21 | — | — | WO | claimed |
| US-20230134462-A1 | COMPOSITE ELECTROLYTE, PROTECTIVE FILM INCLUDING COMPOSITE ELECTROLYTE, PROTECTED NEGATIVE ELECTRODE INCLUDING THE PROTECTIVE FILM, AND LITHIUM METAL BATTERY INCLUDING THE PROTECTED NEGATIVE ELECTRODE | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| US-11600815-B2 | Composite electrolyte, protective film including composite electrolyte, protected negative electrode including the protective film, and lithium metal battery including the protected | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-03-07 | — | — | US | disclosed |
| EP-3499628-A1 | COMPOSITE ELECTROLYTE, PROTECTIVE FILM INCLUDING COMPOSITE ELECTROLYTE, PROTECTED NEGATIVE ELECTRODE INCLUDING THE PROTECTIVE FILM, AND LITHIUM METAL BATTERY INCLUDING THE PROTECTED NEGATIVE ELECTRODE | Samsung Electronics Co., Ltd. (KR) | 2019-06-19 | — | — | EP | disclosed |
| US-20190181435-A1 | COMPOSITE ELECTROLYTE, PROTECTIVE FILM INCLUDING COMPOSITE ELECTROLYTE, PROTECTED NEGATIVE ELECTRODE INCLUDING THE PROTECTIVE FILM, AND LITHIUM METAL BATTERY INCLUDING THE PROTECTED NEGATIVE ELECTRODE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-06-13 | — | — | US | disclosed |
| CN-103998432-A | Bicyclic compounds | TAKEDA PHARMACEUTICAL | 2014-08-20 | — | — | CN | disclosed |
| EP-1307450-B1 | 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones | WARNER LAMBERT CO (US) | 2008-09-17 | — | — | EP | disclosed |
| EP-0823908-B1 | PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION | WARNER LAMBERT CO (US) | 2006-11-02 | — | — | EP | disclosed |
| US-7022711-B2 | 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones | WARNER-LAMBERT COMPANY (US) | 2006-04-04 | — | — | US | disclosed |
| US-6960662-B2 | Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones | WARNER-LAMBERT COMPANY (US) | 2005-11-01 | — | — | US | disclosed |
| WO-2002012238-A2 | 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES | WARNER-LAMBERT COMPANY (US) | 2002-02-14 | — | — | WO | disclosed |
| WO-2002012237-A2 | PROCESS FOR PREPARING 2-(4-PYRIDYL)AMINO-6-DIALKYLOXYPHENYL-PYRIDO[2,3-D]PYRIMIDIN-7-ONES | WARNER-LAMBERT COMPANY (US) | 2002-02-14 | — | — | WO | disclosed |
| US-5945422-A | ANTICANCER AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS | WARNER-LAMBERT COMPANY (US) | 1999-08-31 | — | — | US | disclosed |
| CN-1183099-A | Pyrido [2, 3-d ] pyrimidines for inhibiting protein tyrosine kinase mediated cell proliferation | WARNER LAMBERT CO (US) | 1998-05-27 | — | — | CN | disclosed |
| US-5733914-A | Pyrido 2, 3-d!pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation | WARNER-LAMBERT COMPANY (US) | 1998-03-31 | — | — | US | disclosed |
| EP-0823908-A1 | PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION | WARNER-LAMBERT COMPANY (US) | 1998-02-18 | — | — | EP | disclosed |
| US-5620981-A | ANTICARCINOGENIC AGENTS, ATHEROSCLEROSIS, RESTENOSIS, PSORIASIS | WARNER-LAMBERT COMPANY (US) | 1997-04-15 | — | — | US | disclosed |
| WO-1996034867-A1 | PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION | WARNER-LAMBERT COMPANY (US) | 1996-11-07 | — | — | WO | disclosed |
| EP-0154190-A1 | Pyridones | MERCK PATENT GmbH (DE) | 1985-09-11 | — | — | EP | disclosed |